FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

de Solo Alberto		 2. Issuer Name and Ticker or Trading Symbol

CareMax, Inc. [ CMAX ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP and COO
(Last)          (First)          (Middle)

C/O CAREMAX, INC. 1000 NW 57 COURT, SUITE 400		 3. Date of Earliest Transaction (MM/DD/YYYY)

11/11/2022
(Street)

MIAMI, FL 33126
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 11/11/2022  M  6300 A (1)6300 D  
Class A Common Stock         2894429 I C.G.D. Investment Group (2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units  (3)11/11/2022  M     6300 (1)  (4) (4)Class A Common Stock 6300 (1)$0.00 12600 D  
Explanation of Responses:
(1) On November 11, 2022, the reporting person received shares of common stock of the issuer in settlement of restricted stock units, which vested on October 29, 2022.
(2) The reported securities are held by C.G.D. Investment Group ("C.G.D."). Mr. de Solo beneficially owns the reported securities owned by C.G.D.
(3) Restricted Stock Units convert into common stock on a one-for-one basis.
(4) On October 29, 2021, the reporting person was granted 18,900 restricted stock units, vesting in three equal installments on October 29, 2022, June 8, 2023, and June 8, 2024.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
de Solo Alberto
C/O CAREMAX, INC. 1000 NW 57 COURT
SUITE 400
MIAMI, FL 33126

EVP and COO
Signatures
/s/ Meredith Longsworth, Esq., as attorney-in-fact for Alberto de Solo11/15/2022
**Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Deerfield Healthcare Tec... (NASDAQ:DFHT)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Deerfield Healthcare Tec... Charts.
Deerfield Healthcare Tec... (NASDAQ:DFHT)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Deerfield Healthcare Tec... Charts.